Cite
Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
MLA
Sánchez Ramírez, Javier, et al. “Does VEGF-Targeted Active Immunotherapy Induce Complete Abrogation of Platelet VEGF Levels?” BMC Research Notes, vol. 12, no. 1, June 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13104-019-4368-z.
APA
Sánchez Ramírez, J., Bequet-Romero, M., Morera Díaz, Y., Hernández-Bernal, F., & Ayala Avila, M. (2019). Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels? BMC Research Notes, 12(1), N.PAG. https://doi.org/10.1186/s13104-019-4368-z
Chicago
Sánchez Ramírez, Javier, Mónica Bequet-Romero, Yanelys Morera Díaz, Francisco Hernández-Bernal, and Marta Ayala Avila. 2019. “Does VEGF-Targeted Active Immunotherapy Induce Complete Abrogation of Platelet VEGF Levels?” BMC Research Notes 12 (1): N.PAG. doi:10.1186/s13104-019-4368-z.